Recently, Japan's Kobayashi Pharmaceutical Company fell into a drug safety storm because of a health care product containing red yeast rice raw materials. Japan's Ministry of Health, Labor and Welfare reported that as of April 16, 235 people had been hospitalized for taking the supplement, raising public concerns about the safety of the drug.
Loading...
Kobayashi Pharmaceutical, a world-renowned manufacturer of pharmaceuticals and health products, is now faced with the challenge of drug safety. Red yeast rice, as a common ingredient in Chinese herbal medicines, is widely welcomed for its effect on regulating blood lipids and lowering blood pressure. However, excessive or improper use of red yeast rice ingredients may cause damage to the human body. In this case, the symptoms of abnormal liver function were common among hospitalized patients, which were directly related to the consumption of health products containing red yeast rice raw materials.
In the face of public doubts and criticism, Kobayashi Pharmaceutical Company quickly responded. They suspended the sale of the health products involved, publicly apologized to consumers, and promised to fully cooperate with the relevant authorities in the investigation, find out the cause and take practical and effective measures to ensure that similar incidents do not happen again. Kobayashi said it would revisit its production processes and quality management system to ensure the safety and effectiveness of each product.
Japan's Ministry of Health, Labor and Welfare also attaches great importance to this matter, strengthens the supervision of the drug market, and strictly reviews the qualifications and product quality of drug manufacturers to ensure the safety of drug use by the public. At the same time, they called on consumers to be vigilant when buying medicines, choose formal channels to buy, and use them correctly according to the instructions.
This incident reminds us once again that drug safety is no small matter. Pharmaceutical manufacturers should always put the life and health of consumers first, strictly abide by relevant laws, regulations and standards to ensure product quality and safety. At the same time, consumers should also raise their awareness of self-protection and choose and use drugs correctly.
We hope that Kobayashi Pharmaceutical will be able to identify the cause as soon as possible and take effective measures to restore consumer confidence. At the same time, we also hope that the relevant departments can strengthen supervision to ensure the healthy and orderly development of the drug market. Drug safety is related to the life and health of the people, and requires the joint efforts of the whole society. Let's work together to build a safe and healthy pharmaceutical market environment!